Anitocabtagene autoleucel is an investigational therapy. Neither Kite or Arcellx has received approval from any regulatory authority for any use of this therapy, and its safety and efficacy has not ...

As industry leaders gather at the annual event in Phoenix, the cell and gene therapy space remains in a state of flux, with M ...

Stem cell transplants that are a standard treatment for certain blood cancers are out of reach for many patients. The procedure requires cells from a matched donor, but a match isn’t always available.

Sana Biotechnology, Inc. is working on a gene therapy to cure Type 1 diabetes. Click here to find out why SANA stock is a ...

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces participation and ...

Research Triangle Park, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- One oral presentation and five poster presentations will highlight exciting progress in AskBio’s pipeline and advancements in the ...

SAN DIEGO—Cytiva has launched its Sefia next-generation manufacturing platform, with the goal of helping drug developers and larger healthcare providers accelerate their production of chimeric antigen ...

No two batches of cell therapy are identical, because each is made from a different originator cell. For process development scientists tasked with ensuring product quality, this lack of consistency ...

Novo Nordisk has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish ...